Related Experiment Video
Updated: Aug 5, 2026

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
Published on: December 4, 2016
The role of bioassays in the development, licensing and batch control of biotherapeutics
1Biological Consultants of Dorking, Surrey, UK.
Abstract:
The role of bioassays in ensuring the safety and efficacy of medicines produced by biotechnology intended for human use is under continuous review. It is a complex area, in which the rapid scientific and technological advances have been accompanied, more or less synchronously, by novel clinical applications. The need to match the rapidity of these developments with the necessarily more cautious regulatory procedures for licensing and controlling medicines in the pharmaceutical marketplace has produced an area of active debate. This article reviews the debate and its practical consequences, while maintaining the pre-eminence of the underlying scientific values.
Related Concept Videos
Bioequivalence: Overview
Preclinical Development: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioequivalence studies: Biowaivers
Drug Products: Biologics, Biosimilars and Interchangeables

